| | Title | Authors / Editors | Date |
|
unige:84824 |
Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates |
Demeule, Barthelemy; Gurny, Robert; Arvinte, Tudor |
2006 |
|
unige:13277 |
High throughput screening of protein formulation stability: practical considerations |
Capelle, Martinus A. H.; Gurny, Robert; Arvinte, Tudor |
2007 |
|
unige:13282 |
Detection and characterization of protein aggregates by fluorescence microscopy |
Demeule, Barthélemy; Gurny, Robert; Arvinte, Tudor |
2007 |
|
unige:13246 |
Characterization of protein aggregation: the case of a therapeutic immunoglobulin |
Demeule, Barthélemy; Lawrence, M Jayne; Drake, Alex F.; Gurny, Robert; Arvinte, Tudor |
2007 |
|
unige:1 |
High throughput methods to characterize protein permeation and release |
Capelle, Martinus A. H.; Gurny, Robert; Arvinte, Tudor |
2008 |
|
unige:99556 |
Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity |
Vargas Prada Demeule, Angelica; Lange, Norbert; Arvinte, Tudor; Cerny, Radovan; ... Delie Salmon, Florence |
2009 |
|
unige:1206 |
A high throughput protein formulation platform: case study of salmon calcitonin |
Capelle, Martinus A. H.; Gurny, Robert; Arvinte, Tudor |
2009 |
|
unige:9751 |
Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2) |
Luca, Ludmila; Capelle, Martinus A. H.; Machaidze, Gia; Arvinte, Tudor; ... Gurny, Robert |
2010 |
Arvinte, Tudor
add all
remove all
